4.6 Article

Toll-like receptors in older adults

期刊

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
卷 55, 期 9, 页码 1438-1444

出版社

BLACKWELL PUBLISHING
DOI: 10.1111/j.1532-5415.2007.01300.x

关键词

Toll-like receptor; immunosenescence; innate immunity; aging

资金

  1. NCRR NIH HHS [K12 RR17594] Funding Source: Medline
  2. NIAID NIH HHS [N01 AI 50031, T32 AI007517] Funding Source: Medline
  3. NIA NIH HHS [P30 AG021342] Funding Source: Medline

向作者/读者索取更多资源

Toll-like receptors (TLRs) recognize a limited number of conserved elements in pathogens and, by activating antigen-presenting cells such as dendritic cells and monocytes and macrophages, play a crucial role in the immune response to infection and vaccination. Most data on TLR function in the context of human aging focus on responses to lipopolysaccharide, an integral component of gram-negative bacteria, which signals through TLR4. However, such studies have not led to a consensus conclusion and are limited by differences in epidemiological and laboratory methods. A recent comprehensive evaluation of TLR function in monocytes from older adults was conducted using a multivariable mixed statistical model to account for covariates. It was found that cytokine production after TLR1/2 engagement, which is essential for the recognition of triacylated lipopeptides found in a variety of bacteria, is substantially lower in monocytes from older adults. The upregulation of costimulatory proteins such as CD80, essential for optimal activation of T cells, on monocytes from older adults was less for all TLR ligands tested than for cells from young individuals, and the extent of CD80 upregulation predicted subsequent antibody response to influenza immunization. These and other consequences of aging on human TLR function may impair activation of the immune response and contribute to poorer vaccine responses and greater morbidity and mortality from infectious diseases in older adults. Such age-associated alterations have particular relevance in view of the interest in TLR agonists as therapeutic agents not only for infections, but also for allergic, autoimmune, and malignant disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据